These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1726998)

  • 21. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial.
    Russo AM; Poole JE; Mark DB; Anderson J; Hellkamp AS; Lee KL; Johnson GW; Domanski M; Bardy GH
    J Cardiovasc Electrophysiol; 2008 Jul; 19(7):720-4. PubMed ID: 18373605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
    Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The extent of regional wall motion abnormalities identifies patients at risk of extensive left ventricular remodeling: implications for the design of post myocardial infarction trials.
    Zanolla L; Marino P; Golia G; Anselmi M; Zardini P; Borghi C; Ambrosioni E
    G Ital Cardiol; 1999 Jan; 29(1):20-6. PubMed ID: 9987043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of effect of amiodarone on survival after extensive infarction. Polish Amiodarone Trial.
    Budaj A; Kokowicz P; Smielak-Korombel W; Kuch J; Krzemińska-Pakuøa M; Maciejewicz J; Nartowicz E; Zaleska T; Dyduszyński A; Ceremuzyński L
    Coron Artery Dis; 1996 Apr; 7(4):315-9. PubMed ID: 8853584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
    Coats AJ
    Int J Cardiol; 2002 Jan; 82(1):1-5. PubMed ID: 11786150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials.
    Yap YG; Duong T; Bland M; Malik M; Torp-Pedersen C; Køber L; Connolly SJ; Marchant B; Camm J
    Eur Heart J; 2005 Jul; 26(14):1385-93. PubMed ID: 15914501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Procainamide, oxprenolol and amiodarone as antidysrhythmic drugs in myocardial infarction.
    Tuna JL; Correia MJ; d'Almeida VC; Mourão L; da Costa FL; Ribeiro C
    Acta Med Port; 1980 Dec; Suppl 1():27-32. PubMed ID: 6164252
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Freudenberger RS; Hellkamp AS; Halperin JL; Poole J; Anderson J; Johnson G; Mark DB; Lee KL; Bardy GH;
    Circulation; 2007 May; 115(20):2637-41. PubMed ID: 17485579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial.
    Auer J; Weber T; Berent R; Puschmann R; Hartl P; Ng CK; Schwarz C; Lehner E; Strasser U; Lassnig E; Lamm G; Eber B;
    Am Heart J; 2004 Apr; 147(4):636-43. PubMed ID: 15077078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of amiodarone versus metoprolol on the frequency of ventricular arrhythmias and on mortality after acute myocardial infarction. SSSD Investigators. Spanish Study on Sudden Death.
    Navarro-López F; Cosin J; Marrugat J; Guindo J; Bayes de Luna A
    Am J Cardiol; 1993 Dec; 72(17):1243-8. PubMed ID: 7504880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of antiarrhythmic agents after myocardial infarction with special reference to the EMIAT and CAMIAT trials of amiodarone. European Myocardial Infarct Amiodarone Trial. Canadian Amiodarone Myocardial Infarction Trial.
    Jafri SM; Borzak S; Goldberger J; Gheorghiade M
    Prog Cardiovasc Dis; 1998; 41(1):65-70. PubMed ID: 9717860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators.
    Boutitie F; Boissel JP; Connolly SJ; Camm AJ; Cairns JA; Julian DG; Gent M; Janse MJ; Dorian P; Frangin G
    Circulation; 1999 May; 99(17):2268-75. PubMed ID: 10226092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amiodarone and post-MI patients.
    Nademanee K; Singh BN; Stevenson WG; Weiss JN
    Circulation; 1993 Aug; 88(2):764-74. PubMed ID: 7687937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-myocardial infarction mortality in patients with ventricular premature depolarizations. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Pilot Study.
    Cairns JA; Connolly SJ; Gent M; Roberts R
    Circulation; 1991 Aug; 84(2):550-7. PubMed ID: 1860199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.
    Irvine J; Baker B; Smith J; Jandciu S; Paquette M; Cairns J; Connolly S; Roberts R; Gent M; Dorian P
    Psychosom Med; 1999; 61(4):566-75. PubMed ID: 10443767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the minimal dose of amiodarone with antiarrhythmic and hemodynamic activity.
    Mahmarian JJ; Smart FW; Moyé LA; Young JB; Francis MJ; Kingry CL; Verani MS; Pratt CM
    Am J Cardiol; 1994 Oct; 74(7):681-6. PubMed ID: 7524296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of amiodarone on mortality.
    Landray MJ; Kendall MJ
    Lancet; 1998 Feb; 351(9101):523. PubMed ID: 9482474
    [No Abstract]   [Full Text] [Related]  

  • 38. Amiodarone: should we use it more than we do?
    Curtis AB
    Clin Cardiol; 1993 Aug; 16(8):583-4. PubMed ID: 7690318
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study.
    Ceremuzynski L; Kleczar E; Krzeminska-Pakula M; Kuch J; Nartowicz E; Smielak-Korombel J; Dyduszynski A; Maciejewicz J; Zaleska T; Lazarczyk-Kedzia E
    J Am Coll Cardiol; 1992 Nov; 20(5):1056-62. PubMed ID: 1401602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.
    Norris RM
    Lancet; 1997 Jun; 349(9067):1767. PubMed ID: 9193396
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.